HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3.

Abstract
By associating with cyclic AMP-responsive element-binding protein (CREB), the human T-cell leukemia virus type 1 (HTLV-1) Tax protein activates transcription from the HTLV-1 long terminal repeat (LTR), which contains multiple cyclic AMP-responsive elements. The transducers of regulated CREB activity (TORCs) were a recently identified family of CREB co-activators that bind to CREB to enhance CRE-mediated transcription. TORC3, a TORC family protein, dramatically enhances Tax-mediated transcription from the LTR. In this study, we performed a yeast two-hybrid screen using the N-terminal region of TORC3 as bait and identified B-cell chronic lymphatic leukemia protein 3 (BCL3) as a protein interacting with TORC3. This interaction was confirmed by glutathione S-transferase pulldown assays and co-immunoprecipitation experiments with detection by Western blotting. The ankyrin repeat domain of BCL3 interacted with TORC3. By using a luciferase assay, we determined that BCL3 inhibited transcription from the HTLV-1 LTR in a manner dependent on TORC3. Knockdown of endogenous BCL3 using RNA interference enhanced transcriptional activation of CRE. Treatment with trichostatin A, a potent inhibitor of the transcriptional co-repressor HDAC, partially reversed the inhibitory effect of BCL3. These results suggest that BCL3 functions as a repressor of HTLV-1 LTR-mediated transcription through interactions with TORC3. In addition to stimulating transcription from the HTLV-1 LTR, Tax also enhances BCL3 expression; thus, transcription from the LTR is regulated by both positive and negative feedback mechanisms.
AuthorsTakayuki Hishiki, Takayuki Ohshima, Takeshi Ego, Kunitada Shimotohno
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 282 Issue 39 Pg. 28335-28343 (Sep 28 2007) ISSN: 0021-9258 [Print] United States
PMID17644518 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • B-Cell Lymphoma 3 Protein
  • BCL3 protein, human
  • CREB1 protein, human
  • CRTC3 protein, human
  • Cyclic AMP Response Element-Binding Protein
  • Enzyme Inhibitors
  • Gene Products, tax
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Proto-Oncogene Proteins
  • Repressor Proteins
  • Transcription Factors
  • trichostatin A
Topics
  • B-Cell Lymphoma 3 Protein
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Gene Products, tax (metabolism)
  • HeLa Cells
  • Histone Deacetylase Inhibitors
  • Human T-lymphotropic virus 1 (physiology)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Protein Binding (physiology)
  • Protein Structure, Tertiary (physiology)
  • Proto-Oncogene Proteins (metabolism)
  • RNA Interference
  • Repressor Proteins (metabolism)
  • Terminal Repeat Sequences (physiology)
  • Transcription Factors (metabolism)
  • Transcription, Genetic (drug effects, physiology)
  • Transcriptional Activation (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: